Consider Using Auryxia to Bind Phosphate AND Increase Iron

August 2015

Auryxia (aw-RIK-see-uh, ferric citrate) is the first phosphate binder that also increases iron levels in chronic kidney disease patients.

It's an iron-based phosphate binder like Velphoro...but the iron in Auryxia is absorbed so it can help improve anemia.

Auryxia reduces IV iron needs by about 50%...and erythropoiesis-stimulating agents (Epogen, etc) by about 25%...over one year.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote